Experts assess promise of vamorolone to treat Duchenne muscular dystrophy

The drug vamorolone (Agamree) has been hailed as a promising new drug to treat Duchenne muscular dystrophy (DMD). It has recently been approved for clinical use in the United States by the Food and Drug Administration (FDA) and in the European Union by the European Medicines Agency (EMA).

Leave a Comment

Your email address will not be published. Required fields are marked *

Shopping Cart